Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caspase recruitment domain family member 16 (CARD16), commonly abbreviated as CARD16 or COP, is a regulatory protein belonging to the CARD-only proteins (COPs) with inhibitor functions for caspase-1 and caspase-4 activation. CARD16 regulates the proteolytic maturation and release of the pro-inflammatory cytokine interleukin-1 beta (IL-1β) in response to inflammatory stimuli, such as lipopolysaccharide, by controlling the assembly and activity of caspase-1 protein complexes. CARD16 can form oligomers that interact with caspase-1 and modulate cell death in multiple cell types, serving anti-apoptotic and anti-inflammatory roles. It participates in the regulation of signal transduction and gene expression related to inflammatory and stress responses. CARD16 also plays a role in disease, such as restraining apoptosis in cancer cells, contributing to inflammation, and buffering neuronal cells from death in neurodegenerative conditions like Huntington's disease.
Inhibition of caspase-1 and caspase-4 activation, preventing cleavage of pro-IL-1β and downstream inflammation/apoptosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase recruitment domain family member 16 (CARD16).